Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Chifeng Mengxin Pharmaceutical is a Chinese pharmaceutical company based in Inner Mongolia that specializes in the research, development, and large-scale manufacturing of finished dosage forms and active pharmaceutical ingredients (APIs). The company is particularly recognized for its production of corticosteroid drugs, including dexamethasone and prednisone, as well as a variety of antibiotics and cardiovascular treatments. Operating with multiple GMP-certified production lines, Chifeng Mengxin serves both domestic and international markets with a portfolio that includes tablets, capsules, and injections. The firm focuses on providing high-quality, affordable essential medicines across several therapeutic areas such as respiratory, anti-infective, and endocrine health.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Chifeng Mengxin Pharm.